EMEA-002037-PIP01-16 - paediatric investigation plan

Netarsudil

Key facts

• Active Substance:
  Netarsudil
• Therapeutic area:
  Ophthalmology
• Decision number:
  P/0368/2016
• PIP number:
  EMEA-002037-PIP01-16
• Pharmaceutical form(s):
  • Eye drops, solution
  • Solution
• Condition(s) / indication(s):
  Treatment of glaucoma
• Route(s) of administration:
  Ocular use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  21/12/2016

Decision

P/0368/2016: EMA decision of 21 December 2016 on the granting of a product specific waiver for netarsudil (EMEA-002037-PIP01-16)

AdoptedReference Number: EMA/826798/2016